Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation

Dose Response Study Of Lasofoxifene In Postmenopausal Women With Osteoporosis (Placebo-Controlled, Multicenter, Double-Blind, Comparative Study) - Japanese Asian Dose Evaluation: JADE

To establish the optimal dose of lasofoxifene that is fully effective in increasing the BMD in postmenopausal Asian women.

Inclusion Criteria:

• postmenopausal Asian women with osteoporosis defined by low BMD

Exclusion Criteria:

• Metabolic bone disease, use of other osteoporosis drugs or drugs interering with normal bone metabolism